Next Article in Journal
Hydro-Lipophilic Properties of Chlorinated and Brominated 1-Hydroxynaphthalene-2-Carboxanilides
Previous Article in Journal
Synthesis and Spectral Properties of a New Spirophotochromic Molecule
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

1,3-Dipolar Cycloaddition Reactions of 2-Arylmethylidentiazolo[3,2-a]pyrimidines with Azomethinylides: Studying the Supramolecular Organization of Products in the Crystalline Phase †

1
Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Arbuzova 8, 420088 Kazan, Russia
2
A.M. Butlerov Chemical Institute, Kazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia
*
Author to whom correspondence should be addressed.
Presented at the 28th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-28), 15–30 November 2024; Available online: https://sciforum.net/event/ecsoc-28.
Chem. Proc. 2024, 16(1), 24; https://doi.org/10.3390/ecsoc-28-20098
Published: 14 November 2024

Abstract

:
The [3+2]-cycloaddition of azomethinylides formed in situ to dipolarophiles is a promising approach for the synthesis of dispyroderivatives of oxindole and acenaphthenedione. In the course of our studies, it was shown that the cycloaddition of azomethinylides occurs specifically through the exocyclic double C=C bond resulting in the formation of a new pyrrolidine cycle as part of the molecule and, consequently, a dispyroheterocycle. This work is devoted to the synthesis and structural analysis of dispyrothiazolo[3,2-a]pyrimidine in the crystalline phase.

1. Introduction

The reactions of [3+2]-dipolar cycloaddition are interesting to researchers due to the wide range of reagents and the ease of the reaction, and, consequently, the great synthetic potential for the development of fundamental chemical science, as well as for the preparative and industrial preparation of practically important compounds (pharmaceutical industry, agriculture, textile industry, etc.) [1,2,3,4,5].
Thiazolo[3,2-a]pyrimidine derivatives, as a subject of research, were selected not coincidentally. Thiazolopyrimidine and oxindole frameworks are promising structural frameworks for the development of pharmaceutical compounds, since their derivatives are known to possess a range of pharmacological activities, including antipsychotic [6], anti-inflammatory [7], and analgesic [8,9,10,11] effects. Previously, our research group studied the anti-inflammatory activity of various 2-arylmethylidenethiazolo[3,2-a]pyrimidines in relation to cancer cell lines and identified leading compounds against M-Hela, that exhibited efficiency exceeding twice that of the reference drug Sorafenib [12,13].
Similarly to 2-arylmethylidene derivatives of thiazolo[3,2-a]pyrimidine in structure, 2-methylidene carboxylates (Scheme 1, compound A) demonstrate a series of chemical transformations proceeding along the multiple double bonds of the molecule, in some cases playing the role of a dipolarophile. These include interactions with such reagents as cyclic disulfide B, and azomethionylide D (generated from isatin and 1,2,3,4-tetrahydroisoquinoline), leading to the formation of spiroheterocyclic compounds C,E [14,15,16,17].
Hence, single examples of the interaction of 2-substituted thiazolopyrimidines containing a C=C double bond with dipoles have been described in the literature, but the chemical conduct of 2-arylmethylidenethiazolopyrimidines has not been studied in the [3+2]-cycloaddition of the exocyclic double bond of the thiazolidine fragment. This fact allows us to expand the library of potentially important systems containing the thiazolopyrimidine fragment.

2. Materials and Methods

All chemicals were purchased from commercial suppliers and used without addi-tional purification. The 1,2,3,4-tetrahydropyrimidin-2-thiones [18], thiazolo[3,2-a]pyrimidines [19,20], and 2-arylmethylidene derivatives of thiazolo[3,2-a]pyrimidine [21] were synthesized according to the described methods.
NMR experiments were performed on Bruker Avance 400 (Saarbrucken, Germany). Chemical shifts were determined relative to the signals of residual protons of the DMSO-d6. Electrospray ionization (ESI) mass spectra were obtained using a Bruker AmaZon X ion trap mass spectrometer ((Bruker Daltonic GmbH, Germany).
General Method for the Preparation of Compounds 4, 5.
A mixture of 2-arylmethylidentiazolo[3,2-a]pyrimidine (200 mg, 1.0 mmol), 1,2-diketone (2.0 mmol), and sarcosine (80 mg, 2.0 mmol) in methanol (10 mL) was refluxed in an oil bath for an appropriate time of 8–12 h. After completion of the reaction as evident from TLC Hexane/EtOAc 4:1, the reaction was cooled at room temperature. Next, the reaction mixture was filtered off without any further purification.
Spiropyrrolidinoxindole derivative of (Z)-ethyl 2-benzylidene-7-methyl-3-oxo-5-phenyl-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate 4.
Yield 72%, yellow powder, mp 259–263 °C.
1H NMR (500 MHz, CDCl3, 25 °C) δH ppm: 1.17 (t, J = 7.1 Hz, 3H, -CH2CH3), 2.24 (s, 3H, CH3), 2.29 (s, 3H, CH3), 3.43–3.47 (m, 1H, CH2), 4.02–4.10 (m, 2H, -CH2CH3), 4.13–4.18 (m, 1H, CH2), 5.18 (s, 1H, NH), 5.82 (s, 1H, CH-Ph), 6.80–6.83 (m, 3H, CH (Ph)), 7.12–7.16 (m, 1H, CH (isatin)), 7.20–7.21 (m, 3H, CH (Ph)), 7.29–7.32 (m, 3H, CH (isatin)), 7.34–7.37 (m, 3H, CH (Ph)), 7.49–7.51 (m, 1H, CH (Ph)). MS (ESI), m/z, [M + H]+: calcd. for C33H30N4O4S+: 578,68; found: 576,06. Anal. Calcd. for C33H30N4O4S, %: C 68.49; H 5.23; N 9.68; O 11.06; S 5.54. Found C 68.50; H 5.27; N 9.62; O 11.10; S 5.51.
Spiroacenaphthenquinone derivative of (Z)-ethyl 2-benzylidene-7-methyl-3-oxo-5-phenyl-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate 5.
Yield 77%, orange crystals, mp 261–266 °C.
1H NMR (500 MHz, CDCl3, 25 °C) δH ppm: 1.16 (t, J = 7.2 Hz, 3H, -CH2CH3), 2.15 (s, 3H, CH3), 4.00–4.09 (m, 2H, -CH2CH3), 4.13–4.18 (m, 1H, CH2), 4.23–4.27 (m, 1H, CH2), 5.82 (s, 1H, CH-Ph), 7.23–7.25 (m, 3H, CH (Ph)), 7.29–7.30 (m, 2H, CH (Ph)), 7.36–7.37 (m, 3H, CH (Ph)), 7.74–7.78 (m, 2H, CH (Ph)), 7.85 (d, J = 6.8 Hz, 1H, CH (quinone)), 7.90 (d, J = 6.8 Hz, 1H, CH (quinone)) 7.96 (d, J = 8.0 Hz, 1H, CH (quinone)), 8.15 (d, J = 8.0 Hz, 1H, CH (quinone)). 13C NMR (500 MHz, CDCl3, 25 °C) δC ppm: 14.59, 23.02, 35.58, 55.75, 58.62, 60.90, 72.76, 82.02, 108.66, 121.69, 125.10, 126.77, 128.33, 128.57, 129.25, 129.65, 130.69, 131.12, 131.63, 132.71, 134.47, 137.44, 140.39, 144.55, 152.95, 158.28, 165.92, 175.42, 207.30. MS (ESI), m/z, [M + H]+: calcd. for C37H31N3O4S+: 613,72; found: 614,32. Anal. Calcd. for C37H31N3O4S, %: C 72.41; H 5.09; N 6.85; O 10.43; S 5.22. Found C 72.35; H 5.10; N 6.80; O 10.42; S 5.33.
The crystals of 4 suitable for an X-ray diffraction study were obtained by slow evaporation of a solution in DMF/MeOH (3/1 mL) containing 0.02 mol of the dissolved com-pound after 7 days.
The structures of 4 were solved by the direct method using the SHELXT program [22] and refined by the full-matrix least-squares method over F2 using the SHELXL program [23]. All calculations were performed in the WinGX software package [24], the calculation of the geometry of molecules and intermolecular interactions in crystals was carried out using the PLATON program [25], the drawings of molecules were performed using the OR-TEP-3 [24], and MERCURY [26] programs.

3. Results and Discussion

3.1. Synthesis of the Dispyrothiazolo[3,2-a]pyrimidines 4,5

Dispyrothiazolo[3,2-a]pyrimidines 4,5 were synthesized according to Scheme 2. The first step involved the reaction of the 1,2,3,4-tetrahydropyrimidine-2-thiones 1 with ethyl chloroacetate, resulting in the alkylation of the sulfur atom and subsequent cyclization with the formation of thiazolo[3,2-a]pyrimidine-3-one 2 [19,20]. Interaction of the CH-active derivative 2 with benzaldehyde under Knoevenagel reaction conditions led to 2-benzylidenetiazolo[3,2-a]pyrimidine 3 [21]. Finally, three-component condensation of compound 3 with azomethinylides generated in situ from 1,2-diketo derivative and sarcosine gave the target derivatives 4,5 in good yields (69–76%).
The target compounds were obtained in fairly high yields due to the regio- and diastereoselective reaction. The chemical structure was determined on the basis of a number of physicochemical analytical methods, including X-ray single crystal analysis as well as 1H NMR and 13C NMR spectral analysis. Only a single set of signals was detected by 1H NMR analysis, which confirms the selectivity of this method.

3.2. X-Ray Structure of 4

The structure of compound 4, crystallized in trigonal crystal system and space group R3c with one molecule per asymmetric unit and Z = 18, is represented by the only enantiomeric pair out of four possible ones, namely RSRR- and SRSS- isomers. The details of the structure and processing parameters are summarized in Table 1. The X-ray structure with a 50% probability along with atom numbering is given in Figure 1 while the bonding distances and angles are given in Table 1. It is worth noting that an anti-endo approach of the azomethynylide formed during the reaction to the exocyclic double bond of 2-arylmethylidene derivative is carried out. Such regioselectivity is confirmed by NMR and PCA data. Curiously, pores with a diameter of 9 Å were observed during the analysis of the crystalline packaging. The additivity of structure-forming actions of hydrogen bonding of O-H... N-type and weak Van der Waals interactions lead to the realization of porous supramolecular architecture in the crystalline phase (Figure 2).

4. Conclusions

In this work, new dispyrothiazolo[3,2-a]pyrimidines have been synthesized. The use of NMR and X-ray spectroscopy has demonstrated that the reaction of 1,3-dipolar cycloaddition proceeds regio- and diastereoselectively with the formation of only one pair of enanthiomers, namely RSRR- and SRSS- isomers. The formation of a porous structure in crystalline samples of this compound makes them suitable for use as adsorption agents.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ecsoc-28-20098/s1, Figure S1: 1H NMR spectrum (500 MHz, CDCl3, 303 K) of 4; Figure S2: ESI-mass spectrum of 4; Figure S3: 1H NMR spectrum (500 MHz, CDCl3, 303 K) of 5; Figure S4: 13C NMR spectrum (500 MHz, CDCl3, 303 K) of 5; Figure S5: ESI-mass spectrum of 5.

Author Contributions

Conceptualization, A.N. and A.A.; methodology, A.O. and I.L.; validation, A.N., A.A. and I.L.; formal analysis, I.L.; investigation, D.T. and D.M.; resources, I.L.; data curation, A.N., A.A., S.S. and I.A.; writing—original draft preparation, A.N.; writing—review and editing, A.N. and A.A.; visualization, A.N.; supervision, A.N., A.A., S.S. and I.A.; project administration, S.S. and I.A.; funding acquisition, S.S. and I.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by financial support from a government assignment for the Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences (122011800132-5).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are contained within the article or in Supplementary Materials or are available on request from the corresponding author Anna Nefedova.

Acknowledgments

The authors are grateful to the Assigned Spectral-Analytical Center of Shared Facilities for Study of Structure, Composition, and Properties of Substances and Materials of the Federal Research Center of Kazan Scientific Center of Russian Academy of Sciences (CSF-SAC FRC KSC RAS) for technical support.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Karthikeyan, K.; Perumal, P.T.; Etti, S.; Shanmugam, G. Diastereoselective syntheses of pyrazolyl isoxazolidines via 1, 3-dipolar cycloaddition. Tetrahedron 2007, 63, 10581–10586. [Google Scholar] [CrossRef]
  2. Hong, X.; France, S.; Padwa, A. A dipolar cycloaddition approach toward the kopsifoline alkaloid framework. Tetrahedron 2007, 63, 5962–5976. [Google Scholar] [CrossRef] [PubMed]
  3. Liddell, J.R. Pyrrolizidine alkaloids. Nat. Prod. Rep. 1998, 15, 363–370. [Google Scholar] [CrossRef] [PubMed]
  4. Chande, M.S.; Verma, R.S.; Barve, P.A.; Khanwelkar, R.R.; Vaidya, R.B.; Ajaikumar, K.B. Facile synthesis of active antitubercular, cytotoxic and antibacterial agents: Michael addition approach. Eur. J. Med. Chem. 2005, 40, 1143–1148. [Google Scholar] [CrossRef]
  5. Kumar, R.R.; Perumal, S.; Senthilkumar, P.; Yogeeswari, P.; Sriram, D. A highly atom economic, chemo-, regio-and stereoselective synthesis, and discovery of spiro-pyrido-pyrrolizines and pyrrolidines as antimycobacterial agents. Tetrahedron 2008, 64, 2962–2971. [Google Scholar] [CrossRef]
  6. Flefel, E.M.; El-sayed, W.A.; Mohamed, A.M.; El-Sofany, W.I.; Awad, H.M. Synthesis and anticancer activity of new 1-thia-4-azaspiro [4.5] decane, their derived thiazolopyrimidine and 1, 3, 4-thiadiazole thioglycosides. Molecules 2017, 22, 170. [Google Scholar] [CrossRef]
  7. Saha, S.; Mishra, M.K.; Reddy, C.M.; Desiraju, G.R. From molecules to interactions to crystal engineering: Mechanical properties of organic solids. Acc. Chem. Res. 2018, 51, 2957–2967. [Google Scholar] [CrossRef]
  8. Patra, A.; Wijsboom, Y.H.; Leitus, G.; Bendikov, M. Synthesis, structure, and electropolymerization of 3, 4-dimethoxytellurophene: Comparison with selenium analogue. Org. Lett. 2009, 11, 1487–1490. [Google Scholar] [CrossRef]
  9. Alimohammadi, K.; Sarrafi, Y.; Tajbakhsh, M.; Yeganegi, S.; Hamzehloueian, M. An experimental and theoretical investigation of the regio-and stereoselectivity of the polar [3+2] cycloaddition of azomethine ylides to nitrostyrenes. Tetrahedron 2011, 67, 1589–1597. [Google Scholar] [CrossRef]
  10. Wang, Y.C.; Wang, J.L.; Burgess, K.S.; Zhang, J.W.; Zheng, Q.M.; Pu, Y.D.; Yan, L.J.; Chen, X.B. Green synthesis of new pyrrolidine-fused spirooxindoles via three-component domino reaction in EtOH/H2O. RSC Adv. 2018, 8, 5702–5713. [Google Scholar] [CrossRef]
  11. Barkov, A.Y.; Zimnitskiy, N.S.; Korotaev, V.Y.; Kutyashev, I.B.; Moshkin, V.S.; Sosnovskikh, V.Y. Highly regio-and stereoselective 1, 3-dipolar cycloaddition of stabilised azomethine ylides to 3, 3, 3-trihalogeno-1-nitropropenes: Synthesis of trihalomethylated spiro [indoline-3, 2′-pyrrolidin]-2-ones and spiro [indoline-3, 3′-pyrrolizin]-2-ones. Tetrahedron 2016, 72, 6825–6836. [Google Scholar] [CrossRef]
  12. Agarkov, S.; Nefedova, A.A.; Gabitova, E.R.; Mingazhetdinova, D.O.; Ovsyannikov, A.S.; Islamov, D.R.; Amerhanova, S.K.; Lyubina, A.P.; Voloshina, A.D.; Litvinov, I.A.; et al. 2-Hydroxy-3-Methoxybenzylidene) thiazolo [3, 2-a] pyrimidines: Synthesis, Self-Assembly in the Crystalline Phase and Cytotoxic Activity. Int. J. Mol. Sci. 2023, 24, 2084. [Google Scholar] [CrossRef] [PubMed]
  13. Agarkov, A.; Nefedova, A.A.; Gabitova, E.R.; Ovsyannikov, A.S.; Amerhanova, S.K.; Lyubina, A.P.; Voloshina, A.D.; Dorovatovskii, P.V.; Litvinov, I.A.; Solovieva, S.E.; et al. Synthesis, Self-Assembly in Crystalline Phase and Anti-Tumor Activity of 2-(2-/4-Hydroxybenzylidene)thiazolo[3,2-a]pyrimidines. Molecules 2022, 27, 7747. [Google Scholar] [CrossRef] [PubMed]
  14. Ren, D.; Tang, Y.; Yu, X.; Huang, Y.; Li, X. Synthesis of spiro [cyclopent-2/3-ene-1, 2′-[1,3] thiazolo [3, 2-a] pyrimidine] derivatives via 1, 3-dipolar cycloaddition reaction of ethyl buta-2, 3-dienoate. J. Chem. Res. 2018, 42, 631–635. [Google Scholar] [CrossRef]
  15. Ren, D.; Hu, X.; Huang, Y.; Li, X. Synthesis of dispiro [indeno [1,2-b] quinoxaline-11, 3′-pyrrolizine-2′, 2 ″-[1,3] thiazolo [3, 2-a] pyrimidine via cycloaddition reactions. J. Chem. Res. 2018, 42, 453–455. [Google Scholar] [CrossRef]
  16. Qin, L.; Xiaolian, H.; Xiaofang, L. Synthesis of Dispiro [indoline-3, 3′-pyrrolo [2,1-a] isoquinoline-1′, 2′′-thiazolo [3,2-a] pyrimidine] Derivatives via Cycloaddition Reactions. Russ. J. Gen. Chem. 2022, 92, 1822–1826. [Google Scholar] [CrossRef]
  17. Zeng, Q.; Ren, D.; Fu, X.; Li, X. Synthesis of Spiro [Pyrrolo [2,1-b][1,3] Benzothiazole-3, 2′-[1,3] Thiazolo [3, 2-a] Pyrimidine] via Cycloaddition Reactions. J. Chem. Res. 2018, 42, 260–263. [Google Scholar] [CrossRef]
  18. Agarkov, A.S.; Gabitova, E.R.; Galieva, F.B.; Ovsyannikov, A.S.; Voloshina, A.D.; Shiryaev, A.K.; Litvinov, I.A.; Solovieva, S.E.; Antipin, I.S. Structure and Biological Properties of 2-Phenylhydrazone Derivatives of Thiazolopyrimidines. Dokl. Chem. 2022, 503, 45–50. [Google Scholar] [CrossRef]
  19. Agarkov, A.; Kozhikhov, A.A.; Nefedova, A.A.; Ovsyannikov, A.S.; Islamov, D.R.; Solovieva, S.E.; Antipin, I.S. New Method for the Preparation of 2,3-Disubstituted 2,3-Dihydrothiazolo[3,2-a]pyrimidines. Dokl. Chem. 2022, 505, 177–183. [Google Scholar] [CrossRef]
  20. Shiryaev, K.; Kolesnikova, N.G.; Kuznetsova, N.M.; Lashmanova, E.A. Alkylation of tetrahydropyrimidine-2-thions with ethyl chloroacetate. Chem. Heterocycl. Compd. 2013, 49, 1812–1817. [Google Scholar]
  21. Hu, J.; Wang, Y.; Wei, X.; Wu, X.; Chen, G.; Cao, G.; Shen, X.; Zhang, X.; Tang, Q.; Liang, G.; et al. Synthesis and biological evaluation of novel thiazolidinone derivatives as potential anti-inflammatory agents. Eur. J. Med. Chem. 2013, 64, 292–301. [Google Scholar] [CrossRef] [PubMed]
  22. Sheldrick, G. SHELXT—Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  23. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  24. Farrugia, L. WinGXandORTEP for Windows: An update. J. Appl. Crystallogr. 2012, 45, 849–854. [Google Scholar] [CrossRef]
  25. Spek, A. Structure validation in chemical crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 2009, 65, 148–155. [Google Scholar] [CrossRef]
  26. Macrae, C.F.; Edgington, P.R.; McCabe, P.; Pidcock, E.; Shields, G.P.; Taylor, R.; Towler, M.; van de Streek, J. Mercury: Visualization and analysis of crystal structures. J. Appl. Crystallogr. 2006, 39, 453–457. [Google Scholar] [CrossRef]
Scheme 1. 1,3-Dipolar cycloaddition of 2-methylidene carboxylates.
Scheme 1. 1,3-Dipolar cycloaddition of 2-methylidene carboxylates.
Chemproc 16 00024 sch001
Scheme 2. Synthesis Dispyrothiazolo[3,2-a]pyrimidines 4,5. Reagents and conditions: (a) ClCH2CO2Et, 120 °C, no solvent; (b) benzaldehyde, EtOH, pyrollidine, 8 h, reflux; (c,d) 1,2-diketone, sarcosin, MeOH, 9 h, reflux, *—asymmetric carbon atom.
Scheme 2. Synthesis Dispyrothiazolo[3,2-a]pyrimidines 4,5. Reagents and conditions: (a) ClCH2CO2Et, 120 °C, no solvent; (b) benzaldehyde, EtOH, pyrollidine, 8 h, reflux; (c,d) 1,2-diketone, sarcosin, MeOH, 9 h, reflux, *—asymmetric carbon atom.
Chemproc 16 00024 sch002
Figure 1. ORTEP view of molecule 4 in the crystalline phase (a) RSRR-isomer; (b) SRSS-isomer; (C, O, N, S, and H-atoms are presented as gray, red, light-violet, yellow, and light gray ellipsoids with 50% probability, respectively).
Figure 1. ORTEP view of molecule 4 in the crystalline phase (a) RSRR-isomer; (b) SRSS-isomer; (C, O, N, S, and H-atoms are presented as gray, red, light-violet, yellow, and light gray ellipsoids with 50% probability, respectively).
Chemproc 16 00024 g001
Figure 2. ORTEP view of crystal packing of molecule 4 in the crystalline phase (C, O, N, and H-atoms are presented as gray, red, light-violet, and light gray ellipsoids with 50% probability, respectively).
Figure 2. ORTEP view of crystal packing of molecule 4 in the crystalline phase (C, O, N, and H-atoms are presented as gray, red, light-violet, and light gray ellipsoids with 50% probability, respectively).
Chemproc 16 00024 g002
Table 1. Experimental crystal dataset of the target molecule.
Table 1. Experimental crystal dataset of the target molecule.
Compound4 (from DMF/MeOH)
Molecular formulaC33 H30 N4 O4 S
Formula Weight578.67
Crystal Systemtrigonal
Space groupR3c
Cell parametersa 36.777(5) b 36.777(5) c 11.376(2)
α 90 β 90 γ 120
V [Å3]13,325.2
Z and Z′18 and 0
D(calc) [g/cm3]1.298
λ (Å)MoK\α (0.71073)
µ [/mm]0.154
F(000)5472
Theta Min-Max [Deg]1.918–27.489
Reflections measured35,687
Independent reflections6434
Observed reflections [I > 2σ(I)]3725
Goodness of fit0.935
R [I > 2σ(I)]R1 = 0.0653
wR2 = 0.1269
R (all reflections)R1 = 0.1477
wR2 = 0.1565
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nefedova, A.; Tretyakova, D.; Mingazhetdinova, D.; Agarkov, A.; Ovsyannikov, A.; Litvinov, I.; Solovieva, S.; Antipin, I. 1,3-Dipolar Cycloaddition Reactions of 2-Arylmethylidentiazolo[3,2-a]pyrimidines with Azomethinylides: Studying the Supramolecular Organization of Products in the Crystalline Phase. Chem. Proc. 2024, 16, 24. https://doi.org/10.3390/ecsoc-28-20098

AMA Style

Nefedova A, Tretyakova D, Mingazhetdinova D, Agarkov A, Ovsyannikov A, Litvinov I, Solovieva S, Antipin I. 1,3-Dipolar Cycloaddition Reactions of 2-Arylmethylidentiazolo[3,2-a]pyrimidines with Azomethinylides: Studying the Supramolecular Organization of Products in the Crystalline Phase. Chemistry Proceedings. 2024; 16(1):24. https://doi.org/10.3390/ecsoc-28-20098

Chicago/Turabian Style

Nefedova, Anna, Darya Tretyakova, Dilyara Mingazhetdinova, Artem Agarkov, Alexander Ovsyannikov, Igor Litvinov, Svetlana Solovieva, and Igor Antipin. 2024. "1,3-Dipolar Cycloaddition Reactions of 2-Arylmethylidentiazolo[3,2-a]pyrimidines with Azomethinylides: Studying the Supramolecular Organization of Products in the Crystalline Phase" Chemistry Proceedings 16, no. 1: 24. https://doi.org/10.3390/ecsoc-28-20098

APA Style

Nefedova, A., Tretyakova, D., Mingazhetdinova, D., Agarkov, A., Ovsyannikov, A., Litvinov, I., Solovieva, S., & Antipin, I. (2024). 1,3-Dipolar Cycloaddition Reactions of 2-Arylmethylidentiazolo[3,2-a]pyrimidines with Azomethinylides: Studying the Supramolecular Organization of Products in the Crystalline Phase. Chemistry Proceedings, 16(1), 24. https://doi.org/10.3390/ecsoc-28-20098

Article Metrics

Back to TopTop